BIOMAT Database Logo BIOMAT Database Logo

Inhibition of platelet aggregation by a new synthetic compound: 2-[p-(1-oxo-2-isoindolinyl)phenyl] butyric acid (K 3920). 1979

T Di Perri, and A Vittoria, and F Laghi Pasini

The effect of the new synthetic compound 2-[p-(1-oxo--2-isoindolinyl)phenyl] butyric acid (K 3920) on platelet aggregation was assessed in vitro on human platelets. ADP, epinephrine and collagen at different concentrations were employed as inducing agents. From the results of the present study it appears that K 3920 inhibits human platelet aggregation in vitro, probably by acting on the release reaction.

UI MeSH Term Description Entries
D007211 Indoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010654 Phenylbutyrates Derivatives of 4-phenylbutyric acid, including its salts and esters.
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D003094 Collagen A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH). Avicon,Avitene,Collagen Felt,Collagen Fleece,Collagenfleece,Collastat,Dermodress,Microfibril Collagen Hemostat,Pangen,Zyderm,alpha-Collagen,Collagen Hemostat, Microfibril,alpha Collagen
D003864 Depression, Chemical The decrease in a measurable parameter of a PHYSIOLOGICAL PROCESS, including cellular, microbial, and plant; immunological, cardiovascular, respiratory, reproductive, urinary, digestive, neural, musculoskeletal, ocular, and skin physiological processes; or METABOLIC PROCESS, including enzymatic and other pharmacological processes, by a drug or other chemical. Chemical Depression,Chemical Depressions,Depressions, Chemical
D004837 Epinephrine The active sympathomimetic hormone from the ADRENAL MEDULLA. It stimulates both the alpha- and beta- adrenergic systems, causes systemic VASOCONSTRICTION and gastrointestinal relaxation, stimulates the HEART, and dilates BRONCHI and cerebral vessels. It is used in ASTHMA and CARDIAC FAILURE and to delay absorption of local ANESTHETICS. Adrenaline,4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol,Adrenaline Acid Tartrate,Adrenaline Bitartrate,Adrenaline Hydrochloride,Epifrin,Epinephrine Acetate,Epinephrine Bitartrate,Epinephrine Hydrochloride,Epinephrine Hydrogen Tartrate,Epitrate,Lyophrin,Medihaler-Epi,Acetate, Epinephrine
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

T Di Perri, and A Vittoria, and F Laghi Pasini
Distribution of 14C-labelled 2-[p-(1-oxo-2-isoindolinyl)phenyl]butyric acid, (indobufen or K 3920) in blood, platelets and platelet components.
January 1980, Thrombosis research,
T Di Perri, and A Vittoria, and F Laghi Pasini
Preliminary studies on indobufen (K 3920). A new inhibitor of platelet aggregation.
December 1981, Haematologica,
T Di Perri, and A Vittoria, and F Laghi Pasini
Preliminary human pharmacology studies on the inhibition of platelet aggregation by indobufen (K 3920).
April 1981, Haematologica,
T Di Perri, and A Vittoria, and F Laghi Pasini
Non-steroidal anti-inflammatory drugs. III. Structure of indoprofen: 2-[4-(1-oxo-2-isoindolinyl)phenyl]propionic acid.
April 1994, Acta crystallographica. Section C, Crystal structure communications,
T Di Perri, and A Vittoria, and F Laghi Pasini
GLC determination of plasma levels of enantiomers of alpha-(4-(1-oxo-2-isoindolinyl)phenyl)propionic acid.
July 1974, Journal of pharmaceutical sciences,
T Di Perri, and A Vittoria, and F Laghi Pasini
Metabolic fate of the anti-inflammatory agent alpha-(4-(1-oxo-2-isoindolinyl)-phenyl)-propionic acid (K 4277) in the rhesus monkey.
October 1974, Arzneimittel-Forschung,
T Di Perri, and A Vittoria, and F Laghi Pasini
Clinical pharmacology studies with indobufen (K 3920): inhibitor of platelet aggregation.
January 1980, Journal of clinical pharmacology,
T Di Perri, and A Vittoria, and F Laghi Pasini
[Clinico-radiological research with a new synthetic choleretic: 2-(1-hydroxy-4-phenyl-cyclohexyl)-butyric acid (M.G. 4833)].
January 1960, Minerva medica,
T Di Perri, and A Vittoria, and F Laghi Pasini
Inhibition of spontaneous platelet aggregation and adhesion by indobufen (K 3920). A randomized, double-blind crossover study on platelet, coagulation and fibrinolysis function tests.
January 1982, Pharmatherapeutica,
T Di Perri, and A Vittoria, and F Laghi Pasini
Studies on an anti-inflammatory agent. III. Pharmacological investigations of a new non-steroidal anti-inflammatory agent: 2-oxo-3-[4-(1-oxo-2-isoindolinyl)-phenyl]-butanamide (GP 650).
January 1982, Arzneimittel-Forschung,
Copied contents to your clipboard!